Canadian Cardiovascular Society
Professional Development

Inflammation Management

Starts: April 2, 2025 8:00 p.m. ET

Ends: April 2, 2025 9:00 p.m. ET

Registration Opens in a new window


This webinar will highlight evidence-based approaches for diagnosing and managing inflammation, emphasizing how emerging therapies, including GLP-1 RAs, can address inflammation’s systemic effects. The program will address the critical role of inflammation in driving cardiovascular and metabolic diseases. The webinar will focus on equipping healthcare providers with the latest insights and tools to identify and manage inflammation, paving the way for improved patient outcomes.

Program Chair: Dr. Anil Gupta

Faculty: Dr. Subodh Verma, Dr. Eileen O’Meara, and Dr. Gavin Oudit

The session will cover the following learning objectives:

  • Understand Inflammation’s Role in Disease 
  • Examine the biological mechanisms linking systemic inflammation to cardiovascular and metabolic health. 
  • Evaluate Emerging Anti-Inflammatory Therapies 
  • Analyze clinical evidence demonstrating the impact of novel treatments, including GLP-1 RAs, on reducing inflammation and improving patient outcomes. 
  • Enhance Diagnostic and Management Strategies 
  • Improve the ability to identify inflammation-driven conditions and tailor therapeutic approaches for optimal care. 
  • Implement Multidisciplinary Care Approaches 
  • Integrate collaborative, patient-centered strategies to address the complex interplay between inflammation, heart failure, and obesity. 
  • Address Barriers to Effective Inflammation Management 
  • Identify challenges in managing inflammation-related conditions and develop practical solutions to overcome them in diverse patient populations. 

Registration Opens in a new window

Back to top